546 / 1116
Fig. 2. (a) Central axial MRI view of the implanted volume and the titanium–zirconium catheters inside the target (CTV2); (b) dose
distribution in the same slice with the CTV2 drawn in red and the urethra in light blue (the 50%, 75%, 90%, 100%, and 125% isodos...
Carmen Ares, Youri Popowski, Sandro Pampallona, Philippe Nouet, Giovanna Dipasquale, Sabine Bieri, Orhan Özsoy, Michel
Rouzaud, Haleem Khan, Raymond Miralbell
Hypofractionated Boost With High-Dose-Rate Brachytherapy and Open Magnetic Resonance Imaging–Guided Implants for
Locally Aggressive Prostate Cancer: A Sequential Dose-Escalation Pilot Study
International Journal of Radiation Oncology*Biology*Physics, Volume 75, Issue 3, 2009, 656–663
Registration to low-field MRI